GlassScriptPhysician profile
J Rod Gimbel
NPI 1932199627
$25,080.21
in general payments reported to CMS, 2019-2025
23 companies · $1,431 in 2025
The $1,431 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $5,419 · 2021: $1,089 · 2022: $3,380 · 2023: $969 · 2024: $2,599 · 2025: $1,431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,398 · Travel and Lodging: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,398.32 |
| Travel and Lodging | $599.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11,801.18 | 2019-2025 | Lifevest |
| Abbott Laboratories | $4,235.22 | 2019-2025 | Jot Dx, Ensite Precision, Ensite |
| Medtronic Vascular, INC. | $3,445.76 | 2019-2020 | |
| Medtronic, INC. | $2,341.92 | 2021-2025 | Na, Micra, Linq II |
| Boston Scientific Corporation | $926.56 | 2020-2025 | Rhythmia Mapping System, Farapulse, Watchman Access System |
| Biosense Webster, INC. | $643.03 | 2020-2025 | Carto 3, Qdot Micro Catheter |
| Janssen Pharmaceuticals, INC | $452.89 | 2020-2024 | Xarelto |
| Pfizer INC. | $201.37 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $182.40 | 2019-2024 | |
| Cardiofocus, INC. | $173.87 | 2022-2024 | Heartlight System |
| Astrazeneca Pharmaceuticals LP | $138.99 | 2019-2024 | Farxiga |
| Biotronik INC. | $98.98 | 2021-2024 | Amvia Edge, Acticor 7 Vr-T Dx, Biomonitor |
| E.R. Squibb & Sons, L.L.C. | $79.72 | 2022-2025 | Camzyos |
| Cardiva Medical, INC. | $63.56 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade 5f Vcs |
| Sanofi-Aventis U.S. LLC | $62.36 | 2022-2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $40.82 | 2024 | Assure Wcd |
| Impulse Dynamics (USA) INC. | $36.29 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $32.59 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.49 | 2023 | Jardiance |
| Vital Connect, INC | $27.53 | 2024 | Vitalpatch Rtm |
| Cvrx, INC. | $27.06 | 2024 | Barostim Neo System |
| Actelion Pharmaceuticals US, INC. | $17.82 | 2023 | Uptravi, Opsumit |
| Altathera Pharmaceuticals LLC | $17.80 | 2023 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw J Gimbel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.